Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Novo Nordisk Pharmaceutique S.A.S
Woman and Man Max 99 years
Novo Nordisk Pharmaceutique S.A.S
Update Il y a 4 ans
A randomised, multicentric, open labelled, parallel group trial with insulin aspart and insulin detemir, investigating the glycaemic effect and profile in children with Type 1 diabetes, of two separate Levemir® + NovoRapid® injections and extemporaneous mixing. THE Paediatric MIXING TRIAL
The primary objective of the trial is to assess if using insulin detemir mixed with insulin aspart in the same syringe and 2 separates injections of insulin detemir and insulin aspart will have any cl...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Novo Nordisk Pharmaceutique S.A.S
Update Il y a 4 ans
To assess ease of use, acceptability and preference of Norditropin NordiFlex® in subjects on prescribed growth hormone therapy
The primary objective of this study is to investigate how easy/difficult patients/parents assess growth hormone injection using Norditropin NordiFlex® by quantifying the proportion of patients that fi...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Novo Nordisk Pharmaceutique S.A.S
Update Il y a 4 ans
Levemir® in ageing patients with type 2 diabetes A seven-month open-labelled randomised multi-centre two-group parallel trial comparing administration of insulin detemir once daily in the morning versus NPH insulin once daily in the morning in ageing subjects with type 2 diabetes. The 3L Study (Levemir in Late Life) Trial Phase: 4
The aim of the study is to compare two -basal insulin regimens as insulin therapy initiation in ageing type 2 diabetic patients with insulin detemir versus NPH insulin given once daily in the morning.
Country
None
organs
None
Specialty
None
unknown
More information